Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience.

Saved in:
Bibliographic Details
Title: Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience.
Authors: Hersh EM; University of Arizona Cancer Center, Tucson 85724., Metch BS, Muggia FM, Brown TD, Whitehead RP, Budd GT, Rinehart JJ, Crawford ED, Bonnet JD, Behrens BC
Source: Journal of immunotherapy : official journal of the Society for Biological Therapy [J Immunother (1991)] 1991 Dec; Vol. 10 (6), pp. 426-31.
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Raven Press Country of Publication: United States NLM ID: 9102704 Publication Model: Print Cited Medium: Print ISSN: 1053-8550 (Print) Linking ISSN: 10538550 NLM ISO Abbreviation: J Immunother (1991) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1053-8550
DOI:10.1097/00002371-199112000-00006